We're happy to announce the #ArteraAI Prostate Test is the First-and-Only Predictive Test for Therapy Personalization in the 2024 @NCCN Guidelines for #ProstateCancer underscoring the importance of incorporating innovative tools for personalized treatment: https://t.co/g6TTSER7Ma

The Artera team had a great time at #SABCS25! Excited by the momentum around AI-driven diagnostics and their potential to advance precision care in oncology. #BreastCancer #Oncology #ArteraAI #PrecisionMedicine

Artera is advancing precision oncology with multimodal AI biomarkers. Erin Stewart, VP of Clinical Development, and @DrMLChua, radiation oncologist at @nccsingapore, spoke with ITN on how ArteraAI Prostate is expanding to other cancers: https://t.co/ii9aHxvFqR

Great few days at #SUO2025 in Phoenix! Thanks to all who connected with the Artera team to talk AI, precision medicine, and the future of prostate cancer care. #ProstateCancer #Urology #AIinHealthcare #ArteraAI

Exciting news: Announcing the commercial launch of the ArteraAI Prostate Test (Post‑RP) for patients with biochemical recurrence after prostatectomy. AI-driven insights guide salvage therapy decisions, preserve tissue, and support personalized care:

Validation of MMAI & Image-Only AI Digital Path-Based Biomarkers Using RW Data @DrRanaMcKay @urotoday @arteraAI #SUO25 🌞n=991 MMAI; n=886 image-only 🌞36% AS, 23% ADT +/- RT, 41% RP, 15% missing 🌞Both models assoc w/ 10 yr risk of DM & PCSM 🌞Assoc remained after adj for NCCN

Artera’s own Jennifer Archer will be speaking at the #DxStrategySummit hosted by @Q1Productions! She’ll be tackling: “Overcoming Barriers to AI-Driven Diagnostic Adoption.” Don’t miss it. https://t.co/TfzD6cLG7i #AIinHealthcare #Diagnostics #PrecisionMedicine #ArteraAI

We’re heading to Florida for #FUS2025! Excited to connect with the urology community and share how the ArteraAI Prostate Test is helping personalize prostate cancer treatment decisions. #Urology #ProstateCancer #AIinHealthcare #ArteraAI #PrecisionMedicine

We’re headed to San Antonio for #SABCS2025! Looking forward to engaging with the breast cancer research community and sharing how AI can power precision care. Stop by booth #1525 to connect. #BreastCancer #ArteraAI #Oncology

Each November, Artera supports @Movember and men’s health. This year, we introduced our Meaningful Check-Ins Challenge, encouraging calls, coffees, and texts through Dec 22. For every employee who completes three check-ins, we’ll donate to #Movember or mental-health nonprofit. 💙

This Thanksgiving, we’re thankful for: 🧠 Research collaborators 🩺 Clinicians using our tools 💙 The patients we serve 🤝 Partners like CorePlus & @PathNetLab Grateful to work alongside you in advancing personalized prostate cancer care. #ArteraAI #AIinHealthcare

We are excited to share 3 key data presentations at @SABCS, showcasing the validation of our #MMAI model in early-stage #breastcancer across multiple Phase III trials in over 12,000 patients from across the world. Read more here: https://t.co/7lDurtCHdq

We’re headed to Phoenix for #SUO2025 this December 2-5! Looking forward to connecting with urologic oncology experts and sharing how Artera is helping personalize prostate cancer care with AI. #ArteraAI #UrologicOncology #ProstateCancer #PrecisionMedicine

AI is transforming clinical decision support in oncology. Thanks to @CancerWorldmag for spotlighting how platforms like ours are helping personalize cancer care, right from the pathology slide. https://t.co/WhlSQyPlpO #ArteraAI #Oncology #PrecisionMedicine

Your prostate cancer treatment should be fast, clear, and tailored to you. Get the insights you need to make informed decisions. ✅ Recommended in NCCN Guidelines ⏱️ Results in 1–2 days, no new procedures 💰 Financial options available Learn more: https://t.co/huuQQdWPtX

AI and collaboration are advancing prostate cancer care. 🤝 Read how the ArteraAI Prostate Biopsy Assay, part of a £1.9M study with @prostateuk, @UniofOxford, and @NorthBristolNHS teams, is personalizing treatment: https://t.co/uvKIA0UzDk

We recently celebrated #NationalSTEMDay — honoring the curiosity and innovation that drive science and tech forward. At Artera, STEM powers our work in medical AI. We asked leaders Nathan Silberman, Laura Chang, and Erin Stewart what inspired their STEM journeys:

#AI in #Oncology: From Hype to Help 🤖🤝 Oncologists today face more data than ever, genomic profiles, imaging, evolving guidelines, and complex therapy choices. What’s changing fast is how they synthesize it all. That’s where oncology is headed, from AI hype to AI help. The

We're back after a fascinating talk with Dr Laura Chang at @arteraAI about predictive use of AI in digitalised pathology. Tune in to hear more about how tech is improving prognostic and predictive cancer care outcomes! #AI #cancercare #tech

Great connecting with so many urology leaders at #LUGPA2025 in Chicago! Thanks to everyone who stopped by to learn how Artera is helping support smarter, faster decisions in prostate cancer care. #ArteraAI #Urology #ProstateCancer #PrecisionMedicine

#ArteraAI Product Update: On November 3rd, 2025, we released a design update for our Prostate Test Report to improve its clinical interpretability. View a preview of some of these changes in the image below and see the full update here: https://t.co/hnanUjOuTp